Åse Marit Leere Øiestad

  • Scientist PhD
  • +47 23 01 30 96
 

Publications 2019

Bergh MS, Bogen IL, Wohlfarth A, Wilson SR, Øiestad ÅML (2019)
Distinguishing Between Cyclopropylfentanyl and Crotonylfentanyl by Methods Commonly Available in the Forensic Laboratory
Ther Drug Monit, 41 (4), 519-527
DOI 10.1097/FTD.0000000000000617, PubMed 30807539

Publications 2018

Bergh MS, Bogen IL, Wilson SR, Øiestad ÅML (2018)
Addressing the Fentanyl Analogue Epidemic by Multiplex UHPLC-MS/MS Analysis of Whole Blood
Ther Drug Monit, 40 (6), 738-748
DOI 10.1097/FTD.0000000000000564, PubMed 30157097

Høiseth G, Arnestad M, Karinen R, Morini L, Rogde S, Sempio C, Vindenes V, Øiestad ÅML (2018)
Is Hair Analysis Useful in Postmortem Cases?
J Anal Toxicol, 42 (1), 49-54
DOI 10.1093/jat/bkx077, PubMed 28977558

Mardal M, Johansen SS, Davidsen AB, Telving R, Jornil JR, Dalsgaard PW, Hasselstrøm JB, Øiestad ÅM, Linnet K, Andreasen MF (2018)
Postmortem analysis of three methoxyacetylfentanyl-related deaths in Denmark and in vitro metabolite profiling in pooled human hepatocytes
Forensic Sci Int, 290, 310-317
DOI 10.1016/j.forsciint.2018.07.020, PubMed 30107329

Oiestad AML, Berg T, Eliassen E, Wiklund T, Sand K, Oiestad EL (2018)
Separation of isomers of new psychoactive substances and isotope-labeled amphetamines using UHPSFC-MS/MS and UHPLC-MS/MS
J. Liq. Chromatogr. Relat. Technol., 41 (7), 391-400

Thaulow CH, Øiestad ÅML, Rogde S, Andersen JM, Høiseth G, Handal M, Mørland J, Vindenes V (2018)
Can measurements of heroin metabolites in post-mortem matrices other than peripheral blood indicate if death was rapid or delayed?
Forensic Sci Int, 290, 121-128
DOI 10.1016/j.forsciint.2018.06.041, PubMed 30015276

Thaulow CH, Øiestad ÅML, Rogde S, Karinen R, Brochmann GW, Andersen JM, Høiseth G, Handal M, Mørland J, Arnestad M, Øiestad EL, Strand DH, Vindenes V (2018)
Metabolites of Heroin in Several Different Post-mortem Matrices
J Anal Toxicol, 42 (5), 311-320
DOI 10.1093/jat/bky002, PubMed 29409037

Vårdal L, Wong G, Øiestad ÅML, Pedersen-Bjergaard S, Gjelstad A, Øiestad EL (2018)
Rapid determination of designer benzodiazepines, benzodiazepines, and Z-hypnotics in whole blood using parallel artificial liquid membrane extraction and UHPLC-MS/MS
Anal Bioanal Chem, 410 (20), 4967-4978
DOI 10.1007/s00216-018-1147-y, PubMed 29947895

Øiestad ÅML, Karinen R, Rogde S, Nilsen S, Boye Eldor KB, Brochmann GW, Arnestad M, Øiestad EL, Peres MD, Kristoffersen L, Vindenes V (2018)
Comparative Study of Postmortem Concentrations of Antidepressants in Several Different Matrices
J Anal Toxicol, 42 (7), 446-458
DOI 10.1093/jat/bky030, PubMed 29762694

Publications 2017

Bergh MS, Bogen IL, Andersen JM, Øiestad ÅML, Berg T (2017)
Determination of adrenaline, noradrenaline and corticosterone in rodent blood by ion pair reversed phase UHPLC-MS/MS
J Chromatogr B Analyt Technol Biomed Life Sci, 1072, 161-172
DOI 10.1016/j.jchromb.2017.11.016, PubMed 29175696

Hjelmeland K, Gustavsen I, Øiestad EL, Øiestad ÅML, Høiseth G, Mørland J (2017)
Zopiclone concentrations in oral fluid and blood after, administration of therapeutic doses of zopiclone
Forensic Sci Int, 278, 177-183
DOI 10.1016/j.forsciint.2017.07.004, PubMed 28735217

Publications 2016

Andås HT, Enger A, Øiestad ÅM, Vindenes V, Christophersen AS, Huestis MA, Øiestad EL (2016)
Extended Detection of Amphetamine and Methamphetamine in Oral Fluid
Ther Drug Monit, 38 (1), 114-9
DOI 10.1097/FTD.0000000000000248, PubMed 26402425

Bergh MS, Bogen IL, Lundanes E, Øiestad ÅML (2016)
Validated methods for determination of neurotransmitters and metabolites in rodent brain tissue and extracellular fluid by reversed phase UHPLC-MS/MS
J Chromatogr B Analyt Technol Biomed Life Sci, 1028, 120-129
DOI 10.1016/j.jchromb.2016.06.011, PubMed 27336704

Høiseth G, Berg-Hansen GO, Øiestad ÅM, Bachs L, Mørland J (2016)
Impairment due to alcohol, tetrahydrocannabinol, and benzodiazepines in impaired drivers compared to experimental studies
Traffic Inj Prev, 18 (3), 244-250
DOI 10.1080/15389588.2016.1201205, PubMed 27327554

Øiestad EL, Øiestad ÅM, Gjelstad A, Karinen R (2016)
Oral fluid drug analysis in the age of new psychoactive substances
Bioanalysis, 8 (7), 691-710
DOI 10.4155/bio-2015-0027, PubMed 26964619

Publications 2014

Berg T, Karlsen M, Oiestad AM, Johansen JE, Liu H, Strand DH (2014)
Evaluation of ¹³C- and ²H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry
J Chromatogr A, 1344, 83-90
DOI 10.1016/j.chroma.2014.04.020, PubMed 24780257

Karinen R, Tuv SS, Rogde S, Peres MD, Johansen U, Frost J, Vindenes V, Øiestad ÅM (2014)
Lethal poisonings with AH-7921 in combination with other substances
Forensic Sci Int, 244, e21-4
DOI 10.1016/j.forsciint.2014.08.013, PubMed 25216892

Publications 2013

Amundsen I, Oiestad ÅM, Ekeberg D, Kristoffersen L (2013)
Quantitative determination of fifteen basic pharmaceuticals in ante- and post-mortem whole blood by high pH mobile phase reversed phase ultra high performance liquid chromatography-tandem mass spectrometry
J Chromatogr B Analyt Technol Biomed Life Sci, 927, 112-23
DOI 10.1016/j.jchromb.2012.12.039, PubMed 23380540

Publications 2011

Oiestad EL, Johansen U, Oiestad AM, Christophersen AS (2011)
Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry
J Anal Toxicol, 35 (5), 280-93
DOI 10.1093/anatox/35.5.280, PubMed 21619723

Sauve EN, Langødegård M, Ekeberg D, Øiestad AM (2011)
Determination of benzodiazepines in ante-mortem and post-mortem whole blood by solid-supported liquid-liquid extraction and UPLC-MS/MS
J Chromatogr B Analyt Technol Biomed Life Sci, 883-884, 177-88
DOI 10.1016/j.jchromb.2011.10.033, PubMed 22119506

Publications 2010

Gjerde H, Øiestad EL, Øiestad ÅM, Langødegård M, Gustavsen I, Hjelmeland K, Bernard JP, Christophersen AS (2010)
Comparison of zopiclone concentrations in oral fluid sampled with Intercept(®) oral specimen collection device and Statsure Saliva Sampler™ and concentrations in blood
J Anal Toxicol, 34 (9), 590-3
DOI 10.1093/jat/34.9.590, PubMed 21073813

Page visits: 324